Genesis Healthcare, Inc. (GENN) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Genesis Healthcare, Inc. (GENN) trades at $0.0001 with AI Score 46/100 (Grade C). Genesis Healthcare, Inc. operates skilled nursing and assisted living facilities in the United States. Sector: Healthcare.
Price as of Aug 21, 2026 · Last analyzed: Mar 16, 2026Analyst Coverage for GENN: GENN does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates GENN against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
GENN: the 3 scored disciplines are evenly split. Dominant signal: Seth Klarman bullish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Genesis Healthcare, Inc. (GENN) Healthcare & Pipeline Overview
Genesis Healthcare, Inc. provides skilled nursing and rehabilitation services across the United States, operating a network of facilities and offering specialized medical services. Facing competitive pressures and regulatory changes, the company focuses on delivering inpatient and rehabilitation services to a diverse patient base.
What Is the Investment Thesis for GENN?
Genesis Healthcare operates in a challenging environment, reflected in its negative profit margin of -1.5%. The company's gross margin stands at 42.2%. Key value drivers include its extensive network of facilities and the demand for skilled nursing and rehabilitation services. Growth catalysts involve expanding rehabilitation services and optimizing facility operations. Potential risks include regulatory changes, reimbursement pressures, and competition from other healthcare providers. Investors should monitor the company's ability to improve profitability and navigate the evolving healthcare landscape. The company's beta of -1.21 suggests a negative correlation to market movements.
Based on FMP financials and quantitative analysis
GENN Key Highlights
Operates approximately 341 skilled nursing facilities and assisted/senior living communities across 24 states as of December 31, 2020.
- Provides rehabilitation therapy services to approximately 1,400 healthcare locations in 42 states, the District of Columbia, and China.
- Profit margin of -1.5% indicates ongoing challenges in achieving profitability.
- Gross margin of 42.2% reflects the company's ability to manage direct costs effectively.
- Employs approximately 44,000 individuals, highlighting its significant role as an employer in the healthcare sector.
Who Are GENN's Competitors?
GENN is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| BICX BioCorRx Inc. | $0.24 | +0.00% | $6.34M | 52 |
| FTRP Field Trip Health Ltd. | $0.84 | +1.07% | $9.81M | 62 |
| CANO Cano Health, Inc. | $2.30 | -2.13% | $12.4M | 52 |
| NVLPF Nova Leap Health Corp. | $0.36 | +5.30% | $31.4M | 55 |
| ASSF Assisted 4 Living, Inc. | $1.00 | +0.00% | $45.4M | 63 |
| BTMD biote Corp. | $1.44 | +5.88% | $63.5M | 66 |
| JYNT The Joint Corp. | $8.23 | -3.63% | $117M | 75 |
| HWAIF Healwell AI Inc. | $0.57 | +3.64% | $172M | 65 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are GENN's Key Strengths?
Extensive network of facilities.
- Comprehensive range of services.
- Established presence in multiple states.
- Experienced management team.
What Are GENN's Weaknesses?
Negative profit margin.
- High debt levels.
- Exposure to regulatory changes.
- Dependence on government reimbursement programs.
What Could Drive GENN Stock Higher?
Expansion of rehabilitation services to new geographic markets and healthcare settings.
- Strategic partnerships and acquisitions to expand service offerings and geographic reach.
- Technology integration and innovation to improve operational efficiency and patient care.
- Focus on value-based care models to improve patient outcomes and reduce costs.
- Development of specialty programs to cater to specific patient populations and healthcare needs.
What Are the Key Risks for GENN?
Financial-distress signal — its Altman Z-Score of 0.13 sits in the distress zone (elevated bankruptcy risk).
- Increasing competition from other healthcare providers.
- Rising labor costs and staffing shortages.
- Changes in government reimbursement policies.
- Economic downturns and reduced consumer spending.
- Regulatory changes and compliance requirements.
What Are the Growth Opportunities for GENN?
- Expansion of Rehabilitation Services: Genesis Healthcare can expand its rehabilitation therapy services to new geographic markets and healthcare settings. The market for rehabilitation services is projected to grow as the population ages and the demand for post-acute care increases. By leveraging its existing infrastructure and expertise, Genesis Healthcare can capture a larger share of this market, potentially increasing revenue by 10-15% over the next three years.
- Strategic Partnerships and Acquisitions: Genesis Healthcare can pursue strategic partnerships and acquisitions to expand its service offerings and geographic reach. Collaborating with hospitals, physician groups, and other healthcare providers can enhance patient referrals and improve care coordination. Acquiring smaller skilled nursing facilities and assisted living communities can provide access to new markets and patient populations, driving revenue growth and market share gains.
- Technology Integration and Innovation: Investing in technology and innovation can improve operational efficiency, enhance patient care, and reduce costs. Implementing electronic health records (EHRs), telehealth solutions, and remote monitoring devices can streamline workflows, improve communication, and enable more personalized care. These technologies can also help Genesis Healthcare attract and retain patients, improve patient satisfaction, and reduce hospital readmission rates.
- Focus on Value-Based Care: Shifting towards value-based care models can improve patient outcomes, reduce costs, and enhance reimbursement rates. By participating in accountable care organizations (ACOs) and other value-based payment arrangements, Genesis Healthcare can align its incentives with those of payers and providers. This can lead to increased patient referrals, improved care coordination, and higher reimbursement rates, driving revenue growth and profitability.
- Development of Specialty Programs: Genesis Healthcare can develop specialty programs to cater to specific patient populations and healthcare needs. Examples include programs for patients with Alzheimer's disease, Parkinson's disease, and other chronic conditions. By offering specialized care and services, Genesis Healthcare can attract patients with complex medical needs and differentiate itself from competitors. This can lead to increased patient referrals, higher reimbursement rates, and improved patient outcomes.
What Are GENN's Competitive Advantages?
- Extensive network of skilled nursing and assisted living facilities.
- Established relationships with healthcare providers and payers.
- Comprehensive range of rehabilitation therapy services.
- Experience in providing care to diverse patient populations.
What Does GENN Do?
Genesis Healthcare, Inc., founded in 2003 and headquartered in Kennett Square, Pennsylvania, is a major provider of skilled nursing and assisted living services in the United States. The company operates through three segments: Inpatient Services, Rehabilitation Therapy Services, and Other Services. Its Inpatient Services segment includes a network of approximately 341 skilled nursing facilities and assisted/senior living communities across 24 states as of December 31, 2020. The Rehabilitation Therapy Services segment offers physical therapy, occupational therapy, speech-language pathology, and respiratory therapy. These services are provided to approximately 1,400 healthcare locations in 42 states, the District of Columbia, and China. The Other Services segment provides physician, staffing, and other healthcare-related services. Genesis Healthcare was formerly known as FC-GEN Operations Investment, LLC, changing its name in February 2015. The company's focus is on providing comprehensive care and rehabilitation services to patients requiring skilled nursing and assisted living support.
What Products and Services Does GENN Offer?
- Owns and operates skilled nursing facilities.
- Operates assisted/senior living facilities.
- Provides inpatient services.
- Offers rehabilitation therapy services (physical, occupational, speech).
- Supplies respiratory therapy services.
- Offers physician staffing services.
- Provides other healthcare-related services.
How Does GENN Make Money?
- Generates revenue from inpatient services provided at skilled nursing and assisted living facilities.
- Earns revenue from rehabilitation therapy services offered to patients in various healthcare settings.
- Receives payments from Medicare, Medicaid, and private insurance companies.
- Provides staffing and other healthcare-related services to generate additional revenue.
What Industry Does GENN Operate In?
Genesis Healthcare operates within the medical care facilities industry, which is influenced by factors such as an aging population, increasing demand for long-term care services, and evolving regulatory requirements. The industry is competitive, with key players including ACORQ, CHCR, GDBYF, GNBT, and MGFRF. Market trends include a growing emphasis on value-based care, the integration of technology to improve patient outcomes, and the expansion of home-based care services. Genesis Healthcare's position is defined by its extensive network of facilities and its focus on providing comprehensive rehabilitation and skilled nursing services.
Who Are GENN's Key Customers?
- Individuals requiring skilled nursing care.
- Seniors needing assisted living services.
- Patients requiring rehabilitation therapy.
- Hospitals and healthcare facilities needing rehabilitation and respiratory therapy services.
Company Profile
Genesis Healthcare, Inc. operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Kennett Square, US. The company is led by CEO David Sheridan Harrington. GENN has traded publicly since 2007.
Financial Health
Genesis Healthcare, Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 0.13 places it in the distress zone, a signal of elevated financial risk.
Key Financial Metrics
Return on equity for Genesis Healthcare, Inc. stands at 7.5%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -1.5%, showing how much profit it generates from its asset base. A current ratio of 0.23 means current liabilities exceed short-term assets, a liquidity point worth watching.
GENN Valuation & Market Position
Relative to its peer group, GENN's quantitative score of 46/100 is below the peer average of 57/100.
Forward Outlook
Wall Street analysts project Genesis Healthcare, Inc. revenue of about $5.37B for fiscal 2026, with EPS near $-3.38.
GENN Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Extensive network of facilities.
- Comprehensive range of services.
- Established presence in multiple states.
- Experienced management team.
Bear Case
- Negative profit margin.
- High debt levels.
- Exposure to regulatory changes.
- Dependence on government reimbursement programs.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
GENN Latest News
No recent news available for GENN.
GENN Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for GENN.
Price Targets
Wall Street price target analysis for GENN.
GENN MoonshotScore
What does this score mean?
The MoonshotScore rates GENN 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: David Sheridan Harrington
CEO
David Sheridan Harrington serves as the CEO of Genesis Healthcare, overseeing the operations of a large healthcare organization with approximately 44,000 employees. His background includes extensive experience in healthcare management and leadership. He is responsible for setting the strategic direction of the company, managing its financial performance, and ensuring the delivery of high-quality care to patients. Harrington's leadership is focused on driving innovation, improving operational efficiency, and enhancing patient outcomes.
Track Record: Under David Sheridan Harrington's leadership, Genesis Healthcare has focused on navigating the challenges of the healthcare industry, including regulatory changes and reimbursement pressures. Key milestones include efforts to expand rehabilitation services and improve facility operations. His strategic decisions aim to enhance the company's financial performance and ensure the long-term sustainability of its business model.
GENN OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Genesis Healthcare may not meet the minimum financial standards or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial reporting, making it more difficult for investors to assess their financial health and operational performance. Trading on the OTC Other tier typically involves higher risks compared to exchanges like NYSE or NASDAQ due to the lack of stringent listing requirements and regulatory oversight.
- OTC Tier: OTC Other
- Limited financial disclosure and transparency.
- Higher price volatility due to lower trading volume.
- Potential for fraud or manipulation.
- Lack of regulatory oversight and investor protection.
- Going concern risk due to financial distress.
- Verify the company's financial statements and SEC filings.
- Assess the company's business model and competitive landscape.
- Evaluate the company's management team and corporate governance practices.
- Review the company's risk factors and legal disclosures.
- Check for any regulatory actions or investigations.
- Monitor the company's news and press releases.
- Consult with a financial advisor before investing.
- Established history of operations in the healthcare sector.
- Presence of experienced management team.
- Network of skilled nursing and assisted living facilities.
- Provision of essential healthcare services.
- Compliance with regulatory requirements.
Common Questions About GENN (Healthcare)
What does the AI Score mean for GENN?
GENN holds an AI Score of 46/100 (Grade: C). This is an educational research signal, not a buy or sell recommendation. Genesis Healthcare, Inc. operates skilled nursing and assisted living facilities in the United States. The company provides inpatient services, rehabilitation therapy, and other specialty medical …
What does Genesis Healthcare, Inc. do?
Genesis Healthcare, Inc. operates a network of skilled nursing facilities and assisted living communities in the United States. The company provides a range of services, including inpatient care, rehabilitation therapy, and other specialty medical services. Genesis Healthcare focuses on delivering comprehensive care to patients requiring skilled nursing and assisted living support, with a presence in multiple states and a commitment to providing high-quality healthcare services.
What are the main risks for GENN?
Genesis Healthcare faces several key risks, including increasing competition in the skilled nursing and assisted living industry, rising labor costs and staffing shortages, and potential changes in government reimbursement policies. The company's negative profit margin and high debt levels also pose significant financial risks. Regulatory changes and compliance requirements could further impact its operations and profitability. Investors should carefully consider these risks before investing in GENN.
What are the key factors to evaluate for GENN?
Genesis Healthcare, Inc. (GENN) holds an AI score of 46/100 (low). Genesis Healthcare operates in a challenging environment, reflected in its negative profit margin of -1.5%. Not financial advice.
How frequently does GENN data refresh on this page?
GENN's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven GENN's recent stock price performance?
Genesis Healthcare, Inc. (GENN) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Extensive network of facilities. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider GENN overvalued or undervalued right now?
Genesis Healthcare, Inc. (GENN) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research GENN before investing?
Before investing in Genesis Healthcare, Inc. (GENN), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding GENN to a portfolio?
Key strength of Genesis Healthcare, Inc. (GENN): Extensive network of facilities. Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data as of December 31, 2020.
- OTC market data may be limited and less reliable than exchange-listed stocks.
- AI analysis pending for GENN.